Skip navigation

Compliance Is Good Business

DID YOU KNOW whistle-blowers who bring actions against pharmaceutical companies under the false claims act can be entitled to 25 to 30 percent of any settlement? Mary E. Riordan, senior counsel, Office of Inspector General, presented that startling information at her session about the OIG's pharma marketing compliance program during the Annual Conference of the National Task Force on CME Provider/Industry Collaboration, held in September. Whistle-blowers, she said, initiated the recent

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.